Identification
- Generic Name
- PNU-142721
- DrugBank Accession Number
- DB08414
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 306.771
Monoisotopic: 306.034209391 - Chemical Formula
- C13H11ClN4OS
- Synonyms
- Not Available
- External IDs
- PNU-142721
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Avoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events & improve clinical decision support.
- Pharmacodynamics
Not Available
- Mechanism of action
Target Actions Organism UGag-Pol polyprotein Not Available - Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as furo[2,3-c]pyridines. These are aromatic compounds containing a furopyridine ring system, where the O- and the N-atom are at the 1- and 6- position, respectively.
- Kingdom
- Organic compounds
- Super Class
- Organoheterocyclic compounds
- Class
- Furopyridines
- Sub Class
- Furo[2,3-c]pyridines
- Direct Parent
- Furo[2,3-c]pyridines
- Alternative Parents
- Alkylarylthioethers / Aminopyrimidines and derivatives / Halopyrimidines / Pyridines and derivatives / Aryl chlorides / Imidolactams / Furans / Heteroaromatic compounds / Sulfenyl compounds / Azacyclic compounds show 6 more
- Substituents
- Alkylarylthioether / Amine / Aminopyrimidine / Aromatic heteropolycyclic compound / Aryl chloride / Aryl halide / Aryl thioether / Azacycle / Furan / Furo[2,3-c]pyridine show 18 more
- Molecular Framework
- Aromatic heteropolycyclic compounds
- External Descriptors
- Not Available
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- U3D0LYB7P0
- CAS number
- 185220-03-5
- InChI Key
- ATCRIOJPQXDFNY-ZETCQYMHSA-N
- InChI
- InChI=1S/C13H11ClN4OS/c1-7(20-13-17-11(14)5-12(15)18-13)9-4-8-2-3-19-10(8)6-16-9/h2-7H,1H3,(H2,15,17,18)/t7-/m0/s1
- IUPAC Name
- 6-chloro-2-{[(1S)-1-{furo[2,3-c]pyridin-5-yl}ethyl]sulfanyl}pyrimidin-4-amine
- SMILES
- C[C@H](SC1=NC(Cl)=CC(N)=N1)C1=CC2=C(OC=C2)C=N1
References
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.0889 mg/mL ALOGPS logP 3.29 ALOGPS logP 2.95 ChemAxon logS -3.5 ALOGPS pKa (Strongest Basic) 4.42 ChemAxon Physiological Charge 0 ChemAxon Hydrogen Acceptor Count 4 ChemAxon Hydrogen Donor Count 1 ChemAxon Polar Surface Area 77.83 Å2 ChemAxon Rotatable Bond Count 3 ChemAxon Refractivity 81.72 m3·mol-1 ChemAxon Polarizability 29.58 Å3 ChemAxon Number of Rings 3 ChemAxon Bioavailability 1 ChemAxon Rule of Five Yes ChemAxon Ghose Filter Yes ChemAxon Veber's Rule No ChemAxon MDDR-like Rule No ChemAxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption + 0.9962 Blood Brain Barrier + 0.9628 Caco-2 permeable + 0.5 P-glycoprotein substrate Non-substrate 0.8019 P-glycoprotein inhibitor I Non-inhibitor 0.7637 P-glycoprotein inhibitor II Inhibitor 0.5412 Renal organic cation transporter Non-inhibitor 0.8024 CYP450 2C9 substrate Non-substrate 0.8172 CYP450 2D6 substrate Non-substrate 0.8598 CYP450 3A4 substrate Non-substrate 0.6412 CYP450 1A2 substrate Inhibitor 0.9239 CYP450 2C9 inhibitor Inhibitor 0.5174 CYP450 2D6 inhibitor Non-inhibitor 0.9307 CYP450 2C19 inhibitor Inhibitor 0.894 CYP450 3A4 inhibitor Non-inhibitor 0.5246 CYP450 inhibitory promiscuity High CYP Inhibitory Promiscuity 0.8877 Ames test AMES toxic 0.5637 Carcinogenicity Non-carcinogens 0.8819 Biodegradation Not ready biodegradable 1.0 Rat acute toxicity 2.4049 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.8844 hERG inhibition (predictor II) Non-inhibitor 0.867
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS Not Available Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available
Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock newinsights and accelerate drug research.
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
1. DetailsGag-Pol polyprotein
- Kind
- Protein
- Organism
- Not Available
- Pharmacological action
- Unknown
- General Function
- Zinc ion binding
- Specific Function
- Gag-Pol polyprotein: Mediates, with Gag polyrotein, the essential events in virion assembly, including binding the plasma membrane, making the protein-protein interactions necessary to create spher...
- Gene Name
- gag-pol
- Uniprot ID
- P03366
- Uniprot Name
- Gag-Pol polyprotein
- Molecular Weight
- 163287.51 Da
References
- Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]
Drug created at September 15, 2010 21:31 / Updated at June 12, 2020 16:52